The contribution of gut dysfunction to heart failure (HF) pathophysiology is not routinely assessed. We sought to investigate whether biomarkers of gut dysfunction would be useful in assessment of HF (eg, severity, adverse outcomes) and risk stratification.

Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium / Israr, Muhammad Zubair; Zhan, Hong; Salzano, Andrea; Voors, Adriaan A; Cleland, John G; Anker, Stefan D; Metra, Marco; Van Veldhuisen, Dirk J; Lang, Chim C; Zannad, Faiez; Samani, Nilesh J; Ng, Leong L; Suzuki, Toru. - In: AMERICAN HEART JOURNAL. - ISSN 1097-6744. - 248:(2022), pp. 108-119. [10.1016/j.ahj.2022.03.002]

Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium

Metra, Marco;
2022-01-01

Abstract

The contribution of gut dysfunction to heart failure (HF) pathophysiology is not routinely assessed. We sought to investigate whether biomarkers of gut dysfunction would be useful in assessment of HF (eg, severity, adverse outcomes) and risk stratification.
2022
Biomarkers
Carnitine
Choline
Chronic Disease
Humans
Acetylcarnitine
Heart Failure
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/193918
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact